Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan;10(1):e1-e2.
doi: 10.1016/S2213-2600(21)00538-5. Epub 2021 Dec 1.

Does the rise in seasonal respiratory viruses foreshadow the return of invasive pneumococcal disease this winter?

Zahin Amin-Chowdhury  1 , Marta Bertran  2 , Carmen L Sheppard  3 , Seyi Eletu  3 , David Litt  3 , Norman K Fry  4 , Shamez N Ladhani  5
Affiliations

Does the rise in seasonal respiratory viruses foreshadow the return of invasive pneumococcal disease this winter?

Zahin Amin-Chowdhury et al. Lancet Respir Med. 2022 Jan.
No abstract available

PubMed Disclaimer

Conflict of interest statement

CLS, SE, DL, and NKF report payment to their institution for investigator-led research in pneumococcal pneumonia or carriage, or both, in humans by GlaxoSmithKline and Pfizer. All other authors declare no competing interests.

Figures

Figure
Figure
Cases of invasive pneumococcal disease in England from 2016–17 to 2020–21 (A) Number of cases by month for each epidemiological year. (B) Percentage of cases by serotype group for each epidemiological year. (C) Percentage of cases by age group for each epidemiological year. PCV7 serotypes include 4, 6B, 9V, 14, 18C, 19F, and 23F. PCV13 serotypes include additional serotypes not included in PCV7 (ie, 1, 3, 5, 7F, 6A, and 19A). PPV23 serotypes include additional serotypes (except 6A) not included in PCV13 (ie, 2, 8, 9N, 10A, 11A, 12F, 15B, 17F, 20, 22F, and 33F). NVT includes additional serotypes not included in any vaccine. NVT=non-vaccine type. PCV7=7-valent pneumococcal conjugate vaccine. PCV13=13-valent pneumococcal conjugate vaccine. PPV23=23-valent pneumococcal polysaccharide vaccine.
See this image and copyright information in PMC

References

    1. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062. - PMC - PubMed
    1. Brueggemann AB, Jansen van Rensburg MJ, Shaw D, et al. Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data. Lancet Digit Health. 2021;3:e360–e370. - PMC - PubMed
    1. Amin-Chowdhury Z, Aiano F, Mensah A, et al. Impact of the coronavirus disease 2019 (COVID-19) pandemic on invasive pneumococcal disease and risk of pneumococcal coinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): prospective national cohort study, England. Clin Infect Dis. 2021;72:e65–e75. - PMC - PubMed
    1. Danino D, Ben-Shimol S, van der Beek BA, et al. Decline in pneumococcal disease in young children during the COVID-19 pandemic associated with suppression of seasonal respiratory viruses, despite persistent pneumococcal carriage: a prospective cohort study. medRxiv. 2021 doi: 10.1101/2021.07.29.21261308. published online Aug 1. (preprint). - DOI - PMC - PubMed
    1. Ladhani SN, Andrews N, Ramsay ME. Summary of evidence to reduce the two-dose infant priming schedule to a single dose of the 13-valent pneumococcal conjugate vaccine in the national immunisation programme in the UK. Lancet Infect Dis. 2021;21:e93–102. - PubMed

Publication types